pH-Sensitive pullulan–DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinoma-Reference-Cited by-同舟云学术

pH-Sensitive pullulan–DOX conjugate nanoparticles for co-loading PDTC to suppress growth and chemoresistance of hepatocellular carcinoma

Published:2015 Issue:41 Volume:3 Page:8070-8078
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Li Huanan¹²³⁴,Sun Yong⁵⁶⁷⁴,Liang Jie⁵⁶⁷⁴,Fan Yujiang⁵⁶⁷⁴,Zhang Xingdong⁵⁶⁷⁴

Affiliation:

1. College of Biomedical Engineering

2. Chongqing Medical University

3. Chongqing

4. China

5. National Engineering Research Center for Biomaterials

6. Sichuan University

7. Chengdu

Abstract

Co-delivery of DOX and PDTC using pH-sensitive pullulan–DOX conjugate nanoparticles helped to suppress growth and chemoresistance of hepatocellular carcinoma.

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2015/TB/C5TB01210D

Reference39 articles.

1. Cancer statistics, 2013

2. Focus on hepatocellular carcinoma

3. Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis

4. Traceable Multifunctional Micellar Nanocarriers for Cancer-Targeted Co-delivery of MDR-1 siRNA and Doxorubicin

5. TPGS-stabilized NaYbF4:Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multifunctional and stimuli-responsive liposomes in hepatocellular carcinoma diagnosis and therapy;Translational Oncology;2024-07

2. Enhancing Therapeutic Efficacy in Cancer Treatment: Integrating Nanomedicine with Autophagy Inhibition Strategies;ACS Omega;2024-06-18

3. Nanobiotechnology-based strategies in alleviation of chemotherapy-mediated cardiotoxicity;Environmental Research;2023-12

4. Recent advances in pH/enzyme-responsive polysaccharide-small-molecule drug conjugates as nanotherapeutics;Carbohydrate Polymers;2023-07

5. Biopolymeric Prodrug Systems as Potential Antineoplastic Therapy;Pharmaceutics;2022-08-25